Coinbase Founder’s Longevity Startup Triples in Value

Date:




Now worth $3.1 billion, NewLimit plans to test its RNA therapy in alcohol-related liver-disease patients next year.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Energy & Utilities Roundup: Market Talk

Find insight on oil futures and Seatrium in the...

Zimbabwe justice minister introduces bill to extend 83-year-old president’s term

HARARE, Zimbabwe -- Zimbabwe’s justice minister on Tuesday introduced...

Second Judicial District Court warns about fake text messages circulating

ALBUQUERQUE, N.M. (KRQE) – The Second Judicial District Court is...